LCN2 and Parkinson disease: The three molecules above were all reduced in PD in GSE22491 (Figure 6) but increased in GSE100054 (Figure 7), but we found that PPBP was decreased in PD, and PROS1 and LCN2 were increased compared to healthy controls.